

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.75136199 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 4.75136199 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.73343958 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.73343958 |
| 5 | glycine metabolic process (GO:0006544) | 4.59684618 |
| 6 | cysteine metabolic process (GO:0006534) | 4.51284935 |
| 7 | serine family amino acid biosynthetic process (GO:0009070) | 4.50548933 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.40315591 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.29819895 |
| 10 | lysine metabolic process (GO:0006553) | 4.18174143 |
| 11 | lysine catabolic process (GO:0006554) | 4.18174143 |
| 12 | positive regulation of immune response to tumor cell (GO:0002839) | 4.15489150 |
| 13 | regulation of immune response to tumor cell (GO:0002837) | 4.15489150 |
| 14 | regulation of response to tumor cell (GO:0002834) | 4.15489150 |
| 15 | positive regulation of response to tumor cell (GO:0002836) | 4.15489150 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.10268072 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.10268072 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.10268072 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.09403770 |
| 20 | serine family amino acid metabolic process (GO:0009069) | 4.07762618 |
| 21 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.01898738 |
| 22 | DNA double-strand break processing (GO:0000729) | 4.00254380 |
| 23 | urea cycle (GO:0000050) | 3.98687527 |
| 24 | urea metabolic process (GO:0019627) | 3.98687527 |
| 25 | bile acid biosynthetic process (GO:0006699) | 3.98315379 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 3.96216449 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.94740546 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.93792881 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87972563 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.87964613 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.82210178 |
| 32 | mitotic sister chromatid cohesion (GO:0007064) | 3.80040299 |
| 33 | L-serine metabolic process (GO:0006563) | 3.76237423 |
| 34 | ribosome assembly (GO:0042255) | 3.74656428 |
| 35 | proteasome assembly (GO:0043248) | 3.74336613 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.73686017 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 3.71972068 |
| 38 | folic acid metabolic process (GO:0046655) | 3.71481156 |
| 39 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.70069637 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.68067650 |
| 41 | replication fork processing (GO:0031297) | 3.62917659 |
| 42 | transcription from mitochondrial promoter (GO:0006390) | 3.62647631 |
| 43 | GMP metabolic process (GO:0046037) | 3.62634661 |
| 44 | one-carbon metabolic process (GO:0006730) | 3.62032144 |
| 45 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.61541892 |
| 46 | non-recombinational repair (GO:0000726) | 3.61541892 |
| 47 | protein carboxylation (GO:0018214) | 3.60316622 |
| 48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60316622 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 3.59216998 |
| 50 | tetrahydrofolate metabolic process (GO:0046653) | 3.57984088 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.57369649 |
| 52 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.57369649 |
| 53 | complement activation, alternative pathway (GO:0006957) | 3.55327831 |
| 54 | regulation of protein activation cascade (GO:2000257) | 3.52809163 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 3.51205716 |
| 56 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.50000306 |
| 57 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.49105035 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.47117051 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.47117051 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.47117051 |
| 61 | purine nucleotide salvage (GO:0032261) | 3.45430435 |
| 62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.44409500 |
| 63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.44409500 |
| 64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.44013789 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.43520567 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 3.43469562 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.41796663 |
| 68 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.40939006 |
| 69 | regulation of fibrinolysis (GO:0051917) | 3.34654502 |
| 70 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.33403119 |
| 71 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.33403119 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 3.31940997 |
| 73 | regulation of complement activation (GO:0030449) | 3.31728607 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.30278655 |
| 75 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.27290204 |
| 76 | mitochondrial DNA replication (GO:0006264) | 3.27170804 |
| 77 | mitotic recombination (GO:0006312) | 3.26748235 |
| 78 | telomere maintenance via recombination (GO:0000722) | 3.24545597 |
| 79 | aldehyde catabolic process (GO:0046185) | 3.21571274 |
| 80 | bile acid metabolic process (GO:0008206) | 3.20529964 |
| 81 | protein deneddylation (GO:0000338) | 3.19987756 |
| 82 | folic acid-containing compound metabolic process (GO:0006760) | 3.19300067 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 3.15295814 |
| 84 | valine metabolic process (GO:0006573) | 3.14342259 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10571528 |
| 86 | cullin deneddylation (GO:0010388) | 3.10337317 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.09586265 |
| 88 | tyrosine metabolic process (GO:0006570) | 3.07824081 |
| 89 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.05965260 |
| 90 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.05965260 |
| 91 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.05812191 |
| 92 | protein-lipid complex remodeling (GO:0034368) | 3.04148835 |
| 93 | macromolecular complex remodeling (GO:0034367) | 3.04148835 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 3.04148835 |
| 95 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.02554247 |
| 96 | cellular amino acid catabolic process (GO:0009063) | 3.02067400 |
| 97 | negative regulation of cholesterol transport (GO:0032375) | 3.00810412 |
| 98 | negative regulation of sterol transport (GO:0032372) | 3.00810412 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.99698976 |
| 100 | nucleobase biosynthetic process (GO:0046112) | 2.98219566 |
| 101 | establishment of integrated proviral latency (GO:0075713) | 2.98135637 |
| 102 | reverse cholesterol transport (GO:0043691) | 2.97202279 |
| 103 | positive regulation of cell cycle arrest (GO:0071158) | 2.96207541 |
| 104 | purine nucleobase biosynthetic process (GO:0009113) | 2.93981878 |
| 105 | DNA unwinding involved in DNA replication (GO:0006268) | 2.93938664 |
| 106 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.92258518 |
| 107 | cytochrome complex assembly (GO:0017004) | 2.91350805 |
| 108 | positive regulation of ligase activity (GO:0051351) | 2.90844812 |
| 109 | respiratory chain complex IV assembly (GO:0008535) | 2.90350948 |
| 110 | sulfur amino acid biosynthetic process (GO:0000097) | 2.90125462 |
| 111 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.87292332 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 2.87174487 |
| 113 | ethanol oxidation (GO:0006069) | 2.86073307 |
| 114 | mitochondrial RNA metabolic process (GO:0000959) | 2.85788085 |
| 115 | IMP biosynthetic process (GO:0006188) | 2.84262955 |
| 116 | pteridine-containing compound metabolic process (GO:0042558) | 2.83120760 |
| 117 | sulfur amino acid metabolic process (GO:0000096) | 2.82467155 |
| 118 | aspartate family amino acid catabolic process (GO:0009068) | 2.82287869 |
| 119 | indolalkylamine metabolic process (GO:0006586) | 2.82237732 |
| 120 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.81749585 |
| 121 | pseudouridine synthesis (GO:0001522) | 2.81646768 |
| 122 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.80524970 |
| 123 | chromatin remodeling at centromere (GO:0031055) | 2.80351555 |
| 124 | triglyceride homeostasis (GO:0070328) | 2.79273992 |
| 125 | acylglycerol homeostasis (GO:0055090) | 2.79273992 |
| 126 | oxaloacetate metabolic process (GO:0006107) | 2.78476462 |
| 127 | DNA strand elongation (GO:0022616) | 2.76167388 |
| 128 | benzene-containing compound metabolic process (GO:0042537) | 2.76164963 |
| 129 | urate metabolic process (GO:0046415) | 2.75451983 |
| 130 | aspartate family amino acid metabolic process (GO:0009066) | 2.75099738 |
| 131 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.74908225 |
| 132 | isotype switching (GO:0045190) | 2.74908225 |
| 133 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.74908225 |
| 134 | nucleoside salvage (GO:0043174) | 2.74749814 |
| 135 | establishment of viral latency (GO:0019043) | 2.74181369 |
| 136 | bile acid and bile salt transport (GO:0015721) | 2.73524391 |
| 137 | cellular biogenic amine catabolic process (GO:0042402) | 2.73450580 |
| 138 | amine catabolic process (GO:0009310) | 2.73450580 |
| 139 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.73410260 |
| 140 | regulation of cholesterol esterification (GO:0010872) | 2.72509961 |
| 141 | IMP metabolic process (GO:0046040) | 2.71205477 |
| 142 | cellular glucuronidation (GO:0052695) | 2.70984509 |
| 143 | blood coagulation, intrinsic pathway (GO:0007597) | 2.70905530 |
| 144 | drug transport (GO:0015893) | 2.70082160 |
| 145 | CENP-A containing nucleosome assembly (GO:0034080) | 2.69298647 |
| 146 | drug transmembrane transport (GO:0006855) | 2.68863673 |
| 147 | plasma lipoprotein particle clearance (GO:0034381) | 2.68771246 |
| 148 | cellular ketone body metabolic process (GO:0046950) | 2.68641102 |
| 149 | purine-containing compound salvage (GO:0043101) | 2.68395270 |
| 150 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.68249871 |
| 151 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.67198848 |
| 152 | DNA replication checkpoint (GO:0000076) | 2.67182904 |
| 153 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.66461928 |
| 154 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.66461928 |
| 155 | AMP metabolic process (GO:0046033) | 2.66165580 |
| 156 | positive regulation of macrophage differentiation (GO:0045651) | 2.66045598 |
| 157 | carnitine metabolic process (GO:0009437) | 2.65248931 |
| 158 | response to X-ray (GO:0010165) | 2.65091185 |
| 159 | regulation of translation in response to stress (GO:0043555) | 2.65050657 |
| 160 | coenzyme catabolic process (GO:0009109) | 2.64375736 |
| 161 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.63252535 |
| 162 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.63204491 |
| 163 | DNA replication initiation (GO:0006270) | 2.63033753 |
| 164 | negative regulation of protein ubiquitination (GO:0031397) | 2.61595928 |
| 165 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.60463629 |
| 166 | regulation of ligase activity (GO:0051340) | 2.58892478 |
| 167 | regulation of DNA endoreduplication (GO:0032875) | 2.58010369 |
| 168 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.57877810 |
| 169 | cell cycle G1/S phase transition (GO:0044843) | 2.57877810 |
| 170 | DNA-dependent DNA replication (GO:0006261) | 2.54724282 |
| 171 | regulation of translational termination (GO:0006449) | 2.54398641 |
| 172 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.54254279 |
| 173 | DNA ligation (GO:0006266) | 2.52887417 |
| 174 | regulation of cellular amine metabolic process (GO:0033238) | 2.52232998 |
| 175 | activated T cell proliferation (GO:0050798) | 2.51467791 |
| 176 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49481603 |
| 177 | formation of translation preinitiation complex (GO:0001731) | 2.49175745 |
| 178 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.47501520 |
| 179 | rRNA modification (GO:0000154) | 2.47142321 |
| 180 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.46846417 |
| 181 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.46846417 |
| 182 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44059067 |
| 183 | tRNA aminoacylation for protein translation (GO:0006418) | 2.43991969 |
| 184 | protein neddylation (GO:0045116) | 2.43442326 |
| 185 | positive regulation of protein ubiquitination (GO:0031398) | 2.42873824 |
| 186 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.41497105 |
| 187 | amino acid activation (GO:0043038) | 2.40789973 |
| 188 | tRNA aminoacylation (GO:0043039) | 2.40789973 |
| 189 | mitotic sister chromatid segregation (GO:0000070) | 2.40286598 |
| 190 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.38031092 |
| 191 | histone exchange (GO:0043486) | 2.38018258 |
| 192 | necroptotic process (GO:0070266) | 2.37058538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.33922407 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.60028602 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.62609179 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.54046164 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.38177461 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.31511566 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.23687214 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.06374377 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.80349251 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.76175637 |
| 11 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.69571973 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.50447875 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43338901 |
| 14 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.36166864 |
| 15 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.32413950 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.31344003 |
| 17 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.28321693 |
| 18 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.27731016 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.23090780 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.22874067 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.16277426 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.09471464 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08503912 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.06212875 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.04853616 |
| 26 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98299746 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.98013796 |
| 28 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93040213 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.82626032 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80665007 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.77170027 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76322663 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74935050 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72340564 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.71062352 |
| 36 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66777368 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66357828 |
| 38 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65309891 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63780586 |
| 40 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62925861 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62504627 |
| 42 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.57619741 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53185147 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.52914094 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52743338 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51289856 |
| 47 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.48321536 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46116914 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.46115496 |
| 50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45635091 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45183018 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45168230 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44354483 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42483901 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42234744 |
| 56 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.41992409 |
| 57 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39896977 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.38308512 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37447495 |
| 60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36047737 |
| 61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31879603 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31393265 |
| 63 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26543634 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25451333 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23694740 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22477646 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.18581746 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17490591 |
| 69 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15893612 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14518289 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14498412 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14361464 |
| 73 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12439197 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12229132 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11543151 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11471467 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.11266331 |
| 78 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10780410 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09942430 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09894024 |
| 81 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09868621 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.07907883 |
| 83 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07705262 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07294930 |
| 85 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07163886 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06409941 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03977007 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01649709 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01385190 |
| 90 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00441105 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99495339 |
| 92 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.99411291 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99175712 |
| 94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97644145 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96482072 |
| 96 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96066270 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95101509 |
| 98 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94124638 |
| 99 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93904154 |
| 100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93813429 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93180250 |
| 102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92293707 |
| 103 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92074290 |
| 104 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.91719654 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91241209 |
| 106 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90599012 |
| 107 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90107585 |
| 108 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89756296 |
| 109 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87679874 |
| 110 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87490305 |
| 111 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87433233 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87341675 |
| 113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87204595 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86773990 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86208875 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85520600 |
| 117 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.83861024 |
| 118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.83281817 |
| 119 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82738281 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82121909 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81905357 |
| 122 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81630284 |
| 123 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.81355485 |
| 124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80793692 |
| 125 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80741729 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80578137 |
| 127 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.79001938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.51879525 |
| 2 | MP0005360_urolithiasis | 5.45187686 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.80782121 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.59895324 |
| 5 | MP0005365_abnormal_bile_salt | 4.53876658 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.29274283 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46614328 |
| 8 | MP0005670_abnormal_white_adipose | 3.04577732 |
| 9 | MP0003252_abnormal_bile_duct | 2.72603195 |
| 10 | MP0005083_abnormal_biliary_tract | 2.63888836 |
| 11 | MP0009840_abnormal_foam_cell | 2.43612925 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.36042527 |
| 13 | MP0005332_abnormal_amino_acid | 2.28268665 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.24921269 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.15134662 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.12162821 |
| 17 | MP0005387_immune_system_phenotype | 1.97666996 |
| 18 | MP0001790_abnormal_immune_system | 1.97666996 |
| 19 | MP0003693_abnormal_embryo_hatching | 1.96333126 |
| 20 | MP0003186_abnormal_redox_activity | 1.96329256 |
| 21 | MP0009697_abnormal_copulation | 1.93198281 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.92364369 |
| 23 | MP0006082_CNS_inflammation | 1.90276855 |
| 24 | MP0002163_abnormal_gland_morphology | 1.89738177 |
| 25 | MP0003786_premature_aging | 1.84681111 |
| 26 | MP0001764_abnormal_homeostasis | 1.82249506 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.81432042 |
| 28 | MP0000609_abnormal_liver_physiology | 1.78054004 |
| 29 | MP0010094_abnormal_chromosome_stability | 1.77963335 |
| 30 | MP0002006_tumorigenesis | 1.75957519 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.75793163 |
| 32 | MP0005671_abnormal_response_to | 1.72545214 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.66341902 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.64409409 |
| 35 | MP0003195_calcinosis | 1.62472189 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.61968558 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.51827993 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.49824041 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.49114721 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.47018887 |
| 41 | MP0001819_abnormal_immune_cell | 1.46752994 |
| 42 | MP0003868_abnormal_feces_composition | 1.46598251 |
| 43 | MP0002723_abnormal_immune_serum | 1.45219403 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.45165382 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.43645135 |
| 46 | MP0003077_abnormal_cell_cycle | 1.41684060 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.34864717 |
| 48 | MP0006054_spinal_hemorrhage | 1.34535079 |
| 49 | MP0000598_abnormal_liver_morphology | 1.33180944 |
| 50 | MP0008260_abnormal_autophagy | 1.26347607 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.25060571 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24318817 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.23837023 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.23504668 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.23070955 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.23060552 |
| 57 | MP0000716_abnormal_immune_system | 1.22128452 |
| 58 | MP0008469_abnormal_protein_level | 1.11626699 |
| 59 | MP0008057_abnormal_DNA_replication | 1.11122952 |
| 60 | MP0009763_increased_sensitivity_to | 1.10321121 |
| 61 | MP0004147_increased_porphyrin_level | 1.08497604 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.07655638 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.06891323 |
| 64 | MP0008058_abnormal_DNA_repair | 1.06841537 |
| 65 | MP0003436_decreased_susceptibility_to | 1.05824086 |
| 66 | MP0001853_heart_inflammation | 1.03554944 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.03524423 |
| 68 | MP0003448_altered_tumor_morphology | 1.02540556 |
| 69 | MP0005220_abnormal_exocrine_pancreas | 1.01644733 |
| 70 | MP0003303_peritoneal_inflammation | 1.01237768 |
| 71 | MP0003011_delayed_dark_adaptation | 1.00768932 |
| 72 | MP0009785_altered_susceptibility_to | 1.00508642 |
| 73 | MP0001191_abnormal_skin_condition | 0.97393009 |
| 74 | MP0005408_hypopigmentation | 0.97370950 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 0.97057399 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.96733120 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.95902779 |
| 78 | MP0002405_respiratory_system_inflammati | 0.95090182 |
| 79 | MP0000685_abnormal_immune_system | 0.93874395 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 0.91995905 |
| 81 | MP0005451_abnormal_body_composition | 0.91782546 |
| 82 | MP0001851_eye_inflammation | 0.90930798 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.90419934 |
| 84 | MP0002102_abnormal_ear_morphology | 0.89734390 |
| 85 | MP0000490_abnormal_crypts_of | 0.89420194 |
| 86 | MP0000313_abnormal_cell_death | 0.87346016 |
| 87 | MP0003866_abnormal_defecation | 0.87327782 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.86690109 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.86149216 |
| 90 | MP0009764_decreased_sensitivity_to | 0.84908473 |
| 91 | MP0003718_maternal_effect | 0.84871789 |
| 92 | MP0001730_embryonic_growth_arrest | 0.84245907 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.84034604 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.83981396 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.83981396 |
| 96 | MP0003724_increased_susceptibility_to | 0.83499762 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80345457 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.80090573 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.78980809 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.78504347 |
| 101 | MP0008932_abnormal_embryonic_tissue | 0.78292114 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.77352343 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 0.76080553 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.75489608 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.74757522 |
| 106 | MP0005164_abnormal_response_to | 0.74422341 |
| 107 | MP0005025_abnormal_response_to | 0.74376475 |
| 108 | MP0002970_abnormal_white_adipose | 0.74345604 |
| 109 | MP0005266_abnormal_metabolism | 0.73901295 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.72931067 |
| 111 | MP0002132_abnormal_respiratory_system | 0.72162171 |
| 112 | MP0004947_skin_inflammation | 0.72112653 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.70245473 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.70220391 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.69951321 |
| 116 | MP0005647_abnormal_sex_gland | 0.69705725 |
| 117 | MP0010307_abnormal_tumor_latency | 0.69296049 |
| 118 | MP0002722_abnormal_immune_system | 0.67853963 |
| 119 | MP0001881_abnormal_mammary_gland | 0.67836981 |
| 120 | MP0001915_intracranial_hemorrhage | 0.67252866 |
| 121 | MP0005023_abnormal_wound_healing | 0.67073493 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.63344423 |
| 123 | MP0002419_abnormal_innate_immunity | 0.62322424 |
| 124 | MP0001800_abnormal_humoral_immune | 0.62084115 |
| 125 | MP0009053_abnormal_anal_canal | 0.60497240 |
| 126 | MP0001243_abnormal_dermal_layer | 0.60190665 |
| 127 | MP0002429_abnormal_blood_cell | 0.60079155 |
| 128 | MP0002398_abnormal_bone_marrow | 0.59990348 |
| 129 | MP0000350_abnormal_cell_proliferation | 0.59757404 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.59400165 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.59078100 |
| 132 | MP0000604_amyloidosis | 0.58951823 |
| 133 | MP0000858_altered_metastatic_potential | 0.58864201 |
| 134 | MP0000358_abnormal_cell_content/ | 0.58346391 |
| 135 | MP0001873_stomach_inflammation | 0.57234739 |
| 136 | MP0009672_abnormal_birth_weight | 0.56138526 |
| 137 | MP0003984_embryonic_growth_retardation | 0.55357327 |
| 138 | MP0008873_increased_physiological_sensi | 0.55031504 |
| 139 | MP0002080_prenatal_lethality | 0.54788427 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.53614856 |
| 141 | MP0001756_abnormal_urination | 0.53092122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.62913086 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.52617939 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.52592723 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.14572726 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.82010821 |
| 6 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.43812457 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.28617377 |
| 8 | Xanthomatosis (HP:0000991) | 4.11958054 |
| 9 | Hyperammonemia (HP:0001987) | 4.01201265 |
| 10 | Volvulus (HP:0002580) | 4.01137428 |
| 11 | Hypolipoproteinemia (HP:0010981) | 3.80181049 |
| 12 | Papilledema (HP:0001085) | 3.72312089 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 3.71373003 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68396953 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.58381375 |
| 16 | Complement deficiency (HP:0004431) | 3.45543418 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.43526993 |
| 18 | Hyperglycinemia (HP:0002154) | 3.41796470 |
| 19 | Stomatitis (HP:0010280) | 3.39043339 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36818003 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.34253621 |
| 22 | Fat malabsorption (HP:0002630) | 3.30903762 |
| 23 | Oligodactyly (hands) (HP:0001180) | 3.26111572 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.25706903 |
| 25 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.23988340 |
| 26 | Joint hemorrhage (HP:0005261) | 3.16023584 |
| 27 | Ketosis (HP:0001946) | 3.15789287 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.13680336 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.13680336 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12422326 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.10522800 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.09046605 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.05133650 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.04680172 |
| 35 | Acute hepatic failure (HP:0006554) | 3.04674884 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 3.04272124 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.02891406 |
| 38 | Hyperglycinuria (HP:0003108) | 3.02296365 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.01239374 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96174859 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94081829 |
| 42 | Stenosis of the external auditory canal (HP:0000402) | 2.93856849 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.91849178 |
| 44 | Steatorrhea (HP:0002570) | 2.86816889 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.86567636 |
| 46 | Chromsome breakage (HP:0040012) | 2.82776803 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.81757624 |
| 48 | Abnormality of complement system (HP:0005339) | 2.81493584 |
| 49 | Rough bone trabeculation (HP:0100670) | 2.78251981 |
| 50 | Spastic diplegia (HP:0001264) | 2.75045400 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.72224536 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72224536 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.71745521 |
| 54 | Testicular atrophy (HP:0000029) | 2.60700566 |
| 55 | Recurrent viral infections (HP:0004429) | 2.60496602 |
| 56 | Epidermoid cyst (HP:0200040) | 2.60054527 |
| 57 | Encephalitis (HP:0002383) | 2.55464008 |
| 58 | Abnormality of chromosome stability (HP:0003220) | 2.54545263 |
| 59 | Posterior subcapsular cataract (HP:0007787) | 2.52997967 |
| 60 | Myelodysplasia (HP:0002863) | 2.51774120 |
| 61 | Hypoproteinemia (HP:0003075) | 2.49640011 |
| 62 | Abnormality of the anterior horn cell (HP:0006802) | 2.49387319 |
| 63 | Degeneration of anterior horn cells (HP:0002398) | 2.49387319 |
| 64 | Choroideremia (HP:0001139) | 2.47499718 |
| 65 | Lethargy (HP:0001254) | 2.47276735 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.46497532 |
| 67 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45416637 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 2.44832072 |
| 69 | IgM deficiency (HP:0002850) | 2.44175307 |
| 70 | IgG deficiency (HP:0004315) | 2.43169992 |
| 71 | Nausea (HP:0002018) | 2.40832669 |
| 72 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.40753899 |
| 73 | Villous atrophy (HP:0011473) | 2.40753899 |
| 74 | Abnormality of the preputium (HP:0100587) | 2.39606983 |
| 75 | Oral leukoplakia (HP:0002745) | 2.37839432 |
| 76 | Hypercholesterolemia (HP:0003124) | 2.37672851 |
| 77 | Duodenal stenosis (HP:0100867) | 2.37138033 |
| 78 | Small intestinal stenosis (HP:0012848) | 2.37138033 |
| 79 | Cerebral edema (HP:0002181) | 2.36416574 |
| 80 | Metabolic acidosis (HP:0001942) | 2.31557128 |
| 81 | Oligodactyly (HP:0012165) | 2.29526874 |
| 82 | B lymphocytopenia (HP:0010976) | 2.28966386 |
| 83 | Increased hepatocellular lipid droplets (HP:0006565) | 2.28929517 |
| 84 | Optic neuritis (HP:0100653) | 2.28694235 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 2.28694235 |
| 86 | Megaloblastic anemia (HP:0001889) | 2.28289254 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.27808887 |
| 88 | Myositis (HP:0100614) | 2.27132329 |
| 89 | Exertional dyspnea (HP:0002875) | 2.26607481 |
| 90 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.26314745 |
| 91 | Acanthocytosis (HP:0001927) | 2.25413283 |
| 92 | Abnormality of T cells (HP:0002843) | 2.23908621 |
| 93 | T lymphocytopenia (HP:0005403) | 2.23880541 |
| 94 | Diastasis recti (HP:0001540) | 2.22352680 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.22345205 |
| 96 | Orchitis (HP:0100796) | 2.22314512 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.19963474 |
| 98 | Abnormality of purine metabolism (HP:0004352) | 2.19216515 |
| 99 | Gout (HP:0001997) | 2.18377617 |
| 100 | Opisthotonus (HP:0002179) | 2.18346902 |
| 101 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17422657 |
| 102 | Meckel diverticulum (HP:0002245) | 2.16999747 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16682606 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16682606 |
| 105 | Pancytopenia (HP:0001876) | 2.14444055 |
| 106 | Abnormality of T cell number (HP:0011839) | 2.13389442 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.13230897 |
| 108 | Cholecystitis (HP:0001082) | 2.13230897 |
| 109 | Abnormality of glycolysis (HP:0004366) | 2.12073209 |
| 110 | Increased serum pyruvate (HP:0003542) | 2.12073209 |
| 111 | Conjugated hyperbilirubinemia (HP:0002908) | 2.12006108 |
| 112 | Blepharitis (HP:0000498) | 2.11107119 |
| 113 | Abnormal trabecular bone morphology (HP:0100671) | 2.10671994 |
| 114 | Combined immunodeficiency (HP:0005387) | 2.08985759 |
| 115 | Thrombophlebitis (HP:0004418) | 2.08053583 |
| 116 | Abnormality of the ileum (HP:0001549) | 2.07756100 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.07461454 |
| 118 | Abnormality of B cell number (HP:0010975) | 2.06539855 |
| 119 | Severe combined immunodeficiency (HP:0004430) | 2.06404749 |
| 120 | Poikilocytosis (HP:0004447) | 2.05974088 |
| 121 | Ketoacidosis (HP:0001993) | 2.05734733 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05145887 |
| 123 | Hepatic necrosis (HP:0002605) | 2.04961599 |
| 124 | Renal Fanconi syndrome (HP:0001994) | 2.04656786 |
| 125 | Increased serum ferritin (HP:0003281) | 2.03759850 |
| 126 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02137556 |
| 127 | Thrombocytosis (HP:0001894) | 2.00650695 |
| 128 | Cholelithiasis (HP:0001081) | 1.98707373 |
| 129 | Microvesicular hepatic steatosis (HP:0001414) | 1.97335785 |
| 130 | Proximal tubulopathy (HP:0000114) | 1.97101133 |
| 131 | Elevated hepatic transaminases (HP:0002910) | 1.96173787 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.93744011 |
| 133 | Neurodegeneration (HP:0002180) | 1.92504761 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.90879061 |
| 135 | Mitochondrial inheritance (HP:0001427) | 1.89840583 |
| 136 | Esophageal varix (HP:0002040) | 1.89823846 |
| 137 | Abnormal gallbladder morphology (HP:0012437) | 1.89276420 |
| 138 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.89175068 |
| 139 | Myocardial infarction (HP:0001658) | 1.88760840 |
| 140 | Increased CSF lactate (HP:0002490) | 1.88688063 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.87501539 |
| 142 | Neoplasm of the adrenal gland (HP:0100631) | 1.87322642 |
| 143 | Aplastic anemia (HP:0001915) | 1.86494477 |
| 144 | Vomiting (HP:0002013) | 1.86265144 |
| 145 | Pancreatitis (HP:0001733) | 1.85846856 |
| 146 | Ureteral duplication (HP:0000073) | 1.85574627 |
| 147 | Abnormality of the duodenum (HP:0002246) | 1.84713489 |
| 148 | Pulmonary infiltrates (HP:0002113) | 1.84561193 |
| 149 | Recurrent bacterial skin infections (HP:0005406) | 1.84460138 |
| 150 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.84253525 |
| 151 | Rhabdomyolysis (HP:0003201) | 1.83783108 |
| 152 | Spastic paraparesis (HP:0002313) | 1.83261674 |
| 153 | Increased serum lactate (HP:0002151) | 1.81999103 |
| 154 | Reticulocytopenia (HP:0001896) | 1.81981261 |
| 155 | Lactic acidosis (HP:0003128) | 1.80085169 |
| 156 | Hepatosplenomegaly (HP:0001433) | 1.79024561 |
| 157 | Brushfield spots (HP:0001088) | 1.78799834 |
| 158 | Glycosuria (HP:0003076) | 1.78035587 |
| 159 | Abnormality of urine glucose concentration (HP:0011016) | 1.78035587 |
| 160 | Neutropenia (HP:0001875) | 1.78008093 |
| 161 | Abnormal pupillary function (HP:0007686) | 1.77745864 |
| 162 | Increased intramyocellular lipid droplets (HP:0012240) | 1.77739387 |
| 163 | Methylmalonic aciduria (HP:0012120) | 1.77069739 |
| 164 | Clubbing of toes (HP:0100760) | 1.76956830 |
| 165 | Keratoconjunctivitis (HP:0001096) | 1.76940902 |
| 166 | Vascular calcification (HP:0004934) | 1.76567991 |
| 167 | Acute necrotizing encephalopathy (HP:0006965) | 1.76505766 |
| 168 | Neonatal onset (HP:0003623) | 1.75447530 |
| 169 | Increased muscle lipid content (HP:0009058) | 1.75138933 |
| 170 | Renal cortical cysts (HP:0000803) | 1.75123993 |
| 171 | Abnormality of reticulocytes (HP:0004312) | 1.75004089 |
| 172 | Spontaneous abortion (HP:0005268) | 1.74710514 |
| 173 | Multiple enchondromatosis (HP:0005701) | 1.74493301 |
| 174 | Bone marrow hypocellularity (HP:0005528) | 1.74027354 |
| 175 | Lymphoma (HP:0002665) | 1.73916952 |
| 176 | Systemic lupus erythematosus (HP:0002725) | 1.73462124 |
| 177 | Recurrent skin infections (HP:0001581) | 1.73408653 |
| 178 | Thyroiditis (HP:0100646) | 1.73352053 |
| 179 | Cerebral hypomyelination (HP:0006808) | 1.72756821 |
| 180 | Postnatal microcephaly (HP:0005484) | 1.71987566 |
| 181 | Gingival bleeding (HP:0000225) | 1.71207186 |
| 182 | Reticulocytosis (HP:0001923) | 1.71079429 |
| 183 | Recurrent abscess formation (HP:0002722) | 1.70643386 |
| 184 | Malnutrition (HP:0004395) | 1.70252918 |
| 185 | Late onset (HP:0003584) | 1.68881376 |
| 186 | Constricted visual fields (HP:0001133) | 1.68757765 |
| 187 | Palpitations (HP:0001962) | 1.68683214 |
| 188 | Amaurosis fugax (HP:0100576) | 1.68588979 |
| 189 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.68220818 |
| 190 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.66574934 |
| 191 | Birth length less than 3rd percentile (HP:0003561) | 1.63305722 |
| 192 | Abnormal platelet function (HP:0011869) | 1.62928073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.39324766 |
| 2 | EIF2AK1 | 3.13057781 |
| 3 | MST4 | 2.86181407 |
| 4 | WEE1 | 2.81160294 |
| 5 | BUB1 | 2.80126396 |
| 6 | CDC7 | 2.67514220 |
| 7 | NEK1 | 2.52954359 |
| 8 | ACVR1B | 2.51861684 |
| 9 | BMPR2 | 2.48852172 |
| 10 | FLT3 | 2.45642631 |
| 11 | STK16 | 2.22162490 |
| 12 | PKN2 | 2.19170083 |
| 13 | ERN1 | 2.16867718 |
| 14 | NME2 | 2.14797429 |
| 15 | TRIM28 | 2.13283431 |
| 16 | EIF2AK3 | 2.10314155 |
| 17 | NEK2 | 1.92011580 |
| 18 | NUAK1 | 1.83268165 |
| 19 | RPS6KA4 | 1.78494337 |
| 20 | VRK2 | 1.74277558 |
| 21 | SIK3 | 1.69608148 |
| 22 | BRSK2 | 1.67692648 |
| 23 | KDR | 1.65039479 |
| 24 | ERBB3 | 1.60110798 |
| 25 | NEK9 | 1.59428272 |
| 26 | PIK3CG | 1.54096436 |
| 27 | PBK | 1.52042215 |
| 28 | TYK2 | 1.51481391 |
| 29 | TSSK6 | 1.49967491 |
| 30 | TGFBR1 | 1.47306100 |
| 31 | STK39 | 1.45559151 |
| 32 | MAP2K3 | 1.43797063 |
| 33 | TESK2 | 1.43356113 |
| 34 | BCR | 1.41888139 |
| 35 | STK10 | 1.40811281 |
| 36 | VRK1 | 1.32801037 |
| 37 | TTK | 1.32506810 |
| 38 | PDK2 | 1.32301077 |
| 39 | SRPK1 | 1.30794989 |
| 40 | MAP4K1 | 1.29702880 |
| 41 | FGFR4 | 1.28593266 |
| 42 | ERBB4 | 1.23930255 |
| 43 | LRRK2 | 1.23002179 |
| 44 | ZAP70 | 1.21497566 |
| 45 | MAP3K12 | 1.20857470 |
| 46 | TBK1 | 1.19900677 |
| 47 | TXK | 1.19294254 |
| 48 | CDK4 | 1.17081579 |
| 49 | MKNK2 | 1.16624812 |
| 50 | DYRK3 | 1.16289072 |
| 51 | FRK | 1.15625155 |
| 52 | STK3 | 1.13855179 |
| 53 | AURKB | 1.09976369 |
| 54 | SCYL2 | 1.09686408 |
| 55 | MAP3K8 | 1.08714180 |
| 56 | ATR | 1.08327342 |
| 57 | KIT | 1.05068023 |
| 58 | TRIB3 | 1.03651014 |
| 59 | PLK1 | 1.02295088 |
| 60 | PLK4 | 0.98938430 |
| 61 | MAPK11 | 0.98847588 |
| 62 | SIK1 | 0.98578791 |
| 63 | BRD4 | 0.97373870 |
| 64 | PIM2 | 0.97240270 |
| 65 | PIK3CA | 0.96315846 |
| 66 | CSNK1A1L | 0.95569390 |
| 67 | RPS6KB2 | 0.95323268 |
| 68 | CDK8 | 0.95108663 |
| 69 | MAP3K11 | 0.91995995 |
| 70 | MAP3K10 | 0.90571071 |
| 71 | BTK | 0.89188555 |
| 72 | PAK4 | 0.87091444 |
| 73 | PASK | 0.86357901 |
| 74 | EEF2K | 0.85796985 |
| 75 | TEC | 0.85279547 |
| 76 | CCNB1 | 0.84047123 |
| 77 | ITK | 0.83040712 |
| 78 | CDK7 | 0.81611044 |
| 79 | TAF1 | 0.81456448 |
| 80 | PDK3 | 0.78364451 |
| 81 | PDK4 | 0.78364451 |
| 82 | IRAK2 | 0.77229609 |
| 83 | TAOK3 | 0.77123925 |
| 84 | BRSK1 | 0.76939162 |
| 85 | PLK3 | 0.76581818 |
| 86 | PIM1 | 0.76521092 |
| 87 | PTK6 | 0.75882802 |
| 88 | NME1 | 0.74462668 |
| 89 | MAP3K3 | 0.74403400 |
| 90 | TESK1 | 0.73700560 |
| 91 | STK4 | 0.70837414 |
| 92 | TAOK1 | 0.70553841 |
| 93 | PLK2 | 0.69224760 |
| 94 | GRK6 | 0.68360448 |
| 95 | IKBKB | 0.68142838 |
| 96 | JAK3 | 0.66646210 |
| 97 | TLK1 | 0.65532735 |
| 98 | GRK7 | 0.65326860 |
| 99 | OXSR1 | 0.63728380 |
| 100 | CSNK1G3 | 0.62572408 |
| 101 | STK38L | 0.62394847 |
| 102 | TAOK2 | 0.62205542 |
| 103 | ABL2 | 0.61147965 |
| 104 | BLK | 0.60587044 |
| 105 | CDK6 | 0.60571216 |
| 106 | EPHA2 | 0.58696082 |
| 107 | IKBKE | 0.58566294 |
| 108 | MAP3K5 | 0.57621453 |
| 109 | LATS1 | 0.57578445 |
| 110 | TNIK | 0.57151414 |
| 111 | MST1R | 0.56240487 |
| 112 | NEK6 | 0.55880181 |
| 113 | MKNK1 | 0.55690137 |
| 114 | WNK3 | 0.54889894 |
| 115 | CSF1R | 0.54195871 |
| 116 | AURKA | 0.53387030 |
| 117 | IRAK1 | 0.52597332 |
| 118 | CSNK2A1 | 0.51193111 |
| 119 | MAP3K14 | 0.49589055 |
| 120 | IRAK4 | 0.48645670 |
| 121 | CSNK2A2 | 0.47924916 |
| 122 | EIF2AK2 | 0.47215020 |
| 123 | CAMKK2 | 0.47034128 |
| 124 | STK24 | 0.46432198 |
| 125 | TGFBR2 | 0.45775544 |
| 126 | JAK2 | 0.42972251 |
| 127 | WNK4 | 0.41891052 |
| 128 | LCK | 0.41572702 |
| 129 | CHEK1 | 0.41410303 |
| 130 | MARK3 | 0.39635936 |
| 131 | ATM | 0.39519021 |
| 132 | MAP2K6 | 0.38799412 |
| 133 | ZAK | 0.38164443 |
| 134 | LYN | 0.37694159 |
| 135 | FGFR1 | 0.36787897 |
| 136 | CHEK2 | 0.36408939 |
| 137 | IRAK3 | 0.36338963 |
| 138 | MAP4K2 | 0.35353447 |
| 139 | CSK | 0.34850079 |
| 140 | CSNK1G1 | 0.33688508 |
| 141 | BMPR1B | 0.33296255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33738084 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87205776 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.64636629 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.50878116 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36444587 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.35006585 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.28081669 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25282244 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10203874 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.06782990 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03005550 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94440300 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.92585791 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92455377 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91492208 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90731639 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86067607 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85919968 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85240006 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.84228218 |
| 21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.82097807 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78881539 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.77013357 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.76796520 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68608059 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61840803 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61750394 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.61159577 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60316834 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59727701 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53847381 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.52022636 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46989685 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43696971 |
| 35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.42153711 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38529276 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37714111 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37288055 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34745534 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34124742 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33970673 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33729536 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33145331 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31132206 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27638765 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.27396259 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23523246 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22045149 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.22002167 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21820766 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21737978 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20835768 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19676410 |
| 54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16164698 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11294780 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.10827823 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08683287 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04595115 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02054196 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01854808 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00257864 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.97288762 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96178765 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.95598622 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94097884 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.93725410 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92519966 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91922616 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.91604306 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87910265 |
| 71 | Ribosome_Homo sapiens_hsa03010 | 0.87903530 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87517414 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87335378 |
| 74 | RNA transport_Homo sapiens_hsa03013 | 0.87218525 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86437657 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86253835 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83174776 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82238394 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81544802 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.81461949 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81087850 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80863385 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79001429 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.78503302 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74128238 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71372485 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70011041 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.69263705 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.68901293 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.68225802 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.67525211 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65994009 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.64121777 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61522904 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60830051 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.59178383 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59102683 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57758555 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57244572 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56452637 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55819365 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.54201334 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.54078392 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52656382 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51411583 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51291944 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51091443 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49015412 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.48902525 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.47970341 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45323165 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.45299112 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44469300 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44313842 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43866526 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43737475 |
| 117 | Purine metabolism_Homo sapiens_hsa00230 | 0.42469194 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41201712 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.41084427 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41007213 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40788306 |
| 122 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40748456 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40630671 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37961203 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37880514 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37653037 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36385943 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.36125859 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35620243 |
| 130 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35502815 |
| 131 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34582096 |
| 132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34237136 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.34094095 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33095990 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.32844962 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.32373136 |
| 137 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26911798 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22175508 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18029440 |
| 140 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.14210328 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13085274 |

